 |
BGR Worldwide represents Altimmune, the clinical-stage biopharmaceutical company that is working on a COVID-19 vaccine and a treatment for liver disease triggered by the obesity epidemic.
The publicly traded Gaithersburg, MD-based company last month reported positive results for its single-dose intranasal COVID-19 vaccine candidate that has been under study in collaboration with the University of Alabama at Birmingham.
CEO Vipin Garg announced Sept. 1 that human trials would begin during the fourth-quarter for its treatment for NASH (non-alcoholic fatty liver disease), which is on the rise due to the increase in obesity. Currently, there, there is no treatment for NASH.
BGR founding partner Ed Rogers, a veteran of the Reagan and Bush I White House, leads the Altimmune effort.
Brent Del Monte, co-lead of BGR's science & life sciences group; John Stone, co-lead of the FDA & public health group, and Remy Brim, senior health advisor to Democratic Senators Patty Murray and Elizabeth Warren, round out BGR's Altimmune team.
Tencent America, which is part of the Chinese video and electronic giant, has hired Mercury Public Affairs for Washington representation.
Nick Pearson, who was director of Congressional affairs at Google Cloud, has joined First Energy as VP-federal government affairs.
Nvidia, the leader in AI chips and member of Wall Street’s “Magnificent Seven” stock group, has registered as a DC lobbyist.
Trump-tied Ballard Partners has signed to represent the Public Broadcasting Service on issues related to funding and dealing with Elon Musk’s Dept. of Government Efficiency.
Greg Walden, former chair of the House Energy and Commerce Committee, reps Constellation, which is the nation's No. 1 producer of carbon-free electricity.
Have a comment? Send it to
No comments have been submitted for this story yet.